Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | HPGD | P15428 | 5/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.36 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8015935 | 0.79 | HPRT1 (0.44) | ALDH1A1HPGDHSD17B10TSHRTDP1 | |
| SCHEMBL143126 | 0.78 | CYP2C9 (0.46) | ALDH1A1HPGDTSHRCYP1A2KMT2A | |
| SCHEMBL3053893 | 0.78 | ALDH1A1 (0.48) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL1804899 | 0.75 | ALDH1A1 (0.46) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL1782942 | 0.75 | ALDH1A1 (0.46) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL1714903 | 0.73 | ALDH1A1 (0.44) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| Water SCHEMBL28464913 | 0.73 | ALDH1A1 (0.44) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL10905515 | 0.73 | ALDH1A1 (0.43) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL38870 | 0.73 | ALDH1A1 (0.44) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL29439072 | 0.73 | ALDH1A1 (0.44) | ALDH1A1HPGDHSD17B10CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839661-B2 | Rapid formation of supramolecular hydrogels by short peptide and bioactive small molecules | BRANDEIS UNIVERSITY (US) | 2023-12-12 | — | — | US | claimed |
| US-20210128745-A1 | RAPID FORMATION OF SUPRAMOLECULAR HYDROGELS BY SHORT PEPTIDE AND BIOACTIVE SMALL MOLECULES | BRANDEIS UNIVERSITY | 2021-05-06 | — | — | US | claimed |
| WO-2019035928-A1 | RAPID FORMATION OF SUPRAMOLECULAR HYDROGELS BY SHORT PEPTIDE AND BIOACTIVE SMALL MOLECULES | BRANDEIS UNIVERSITY (US) | 2019-02-21 | — | — | WO | claimed |
| WO-2018129171-A1 | ENZYMATICALLY ACTIVATABLE PEPTIDE-REDOX MODULATOR CONJUGATES AND USE THEREOF | BRANDEIS UNIVERSITY (US) | 2018-07-12 | — | — | WO | claimed |
| US-20170037082-A1 | SYNTHETIC PEPTIDES, ENZYMATIC FORMATION OF PERICELLULAR HYDROGELS/NANOFIBRILS, AND METHODS OF USE | BRANDEIS UNIVERSITY | 2017-02-09 | — | — | US | claimed |
| WO-2015157535-A2 | SYNTHETIC PEPTIDES, ENZYMATIC FORMATION OF PERICELLULAR HYDROGELS/NANOFIBRILS, AND METHODS OF USE | BRANDEIS UNIVERSITY (US) | 2015-10-15 | — | — | WO | claimed |
| US-11839661-B2 | Rapid formation of supramolecular hydrogels by short peptide and bioactive small molecules | BRANDEIS UNIVERSITY (US) | 2023-12-12 | — | — | US | disclosed |
| US-20210128745-A1 | RAPID FORMATION OF SUPRAMOLECULAR HYDROGELS BY SHORT PEPTIDE AND BIOACTIVE SMALL MOLECULES | BRANDEIS UNIVERSITY | 2021-05-06 | — | — | US | disclosed |
| EP-3790890-A1 | CYCLIC CELL-PENETRATING PEPTIDES WITH ONE OR MORE HYDROPHOBIC RESIDUES | Ohio State Innovation Foundation (US) | 2021-03-17 | — | — | EP | disclosed |
| WO-2019217682-A1 | CYCLIC CELL-PENETRATING PEPTIDES WITH ONE OR MORE HYDROPHOBIC RESIDUES | OHIO STATE INNOVATION FOUNDATION (US) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019035928-A1 | RAPID FORMATION OF SUPRAMOLECULAR HYDROGELS BY SHORT PEPTIDE AND BIOACTIVE SMALL MOLECULES | BRANDEIS UNIVERSITY (US) | 2019-02-21 | — | — | WO | disclosed |
| WO-2004106356-A1 | FUNCTIONALIZED NUCLEOTIDE DERIVATIVES | SYDDANSK UNIVERSITET (DK) | 2004-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037082-A1 | SYNTHETIC PEPTIDES, ENZYMATIC FORMATION OF PERICELLULAR HYDROGELS/NANOFIBRILS, AND METHODS OF USE | DNPEP, ENPEP, ANPEP | ALDH1A1 2882/4885HPGD 3290/4885HSD17B10 3899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.